SANOFICONR

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Sanofi Cons. Health latest dividend payout ratio is 69.89% and 3yr average dividend payout ratio is 37.98%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

Balance sheet of Sanofi Cons. Health is strong. It shouldn't have solvency or liquidity issues.

The profit is oscillating. The profit of Sanofi Cons. Health is ₹168 Crs for TTM, ₹181 Crs for Dec 2024 and ₹165 Crs for Dec 2023.

The net debt of Sanofi Cons. Health is decreasing. Latest net debt of Sanofi Cons. Health is -₹653.8 Crs as of Dec-24. This is less than Dec-23 when it was -₹3.2 Crs.

Sanofi Cons. Health is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Sanofi Cons. Health is 69.13, while 3 year average PE is 64.38. Also latest EV/EBITDA of Sanofi Cons. Health is 44.73 while 3yr average is 45.85.

There is not enough historical data for the companies share price.

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Sanofi Cons. Health is 60.4% and last quarter promoter holding is 60.4%.

The mutual fund holding of Sanofi Cons. Health is increasing. The current mutual fund holding in Sanofi Cons. Health is 15.09% while previous quarter holding is 14.78%.